Sale to Advarra

Sale to Advarra


Baird served as exclusive financial advisor to Forte Research Systems, Inc. on this transaction


Forte Research Systems, Inc. (“Forte” or the “Company”), a portfolio company of Primus Capital (“Primus”), recently announced its sale to Advarra, a portfolio company of Genstar Capital (“Genstar”). Terms of the transaction were not disclosed. The transaction is expected to close later in September.

Forte provides software and services in the critical areas of clinical trial management, clinical data management and research administration for cancer centers, academic medical centers and health systems. With a strong belief in community, collaboration and standards-based development, Forte also facilitates the Onsemble Community, a customer-exclusive group for peer networking, best practices and support. Twice a year at the Onsemble Conference, clinical research professionals meet in person and discuss the latest challenges and solutions in clinical research. Forte provides all research professionals complimentary blog articles, eBooks, webinars and more to support continuous learning on industry topics. Forte is headquartered in Madison, Wisconsin.

Primus Capital is a growth-oriented private equity firm focused on investing in leading healthcare, software and technology-enabled services companies. Primus has invested in over 130 companies, partnering with exceptional management teams to accelerate growth and create shareholder value by applying its industry knowledge, financial resources and investment experience.

Advarra provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. Its robust regulatory expertise and innovative technology ensure the highest standards of research review are met, while putting participants first and meeting complex human research protection oversight requirements. Advarra supports all phases of research across multiple therapeutic areas and is headquartered in Columbia, Maryland.

Genstar Capital is a leading private equity firm that has been actively investing in high quality companies for over 30 years. Genstar works in partnership with its management teams and its network of strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar currently has approximately $17 billion of assets under management and targets investments focused on targeted segments of the financial services, healthcare, industrial technology and software industries. Genstar is based in San Francisco, California.
Sale to Advarra
September 2019
Forte Research Systems, Inc.
Target Location
North America
Acquiror Location
North America